SEIFEM 2017: from real life to an agreement on the use of granulocyte transfusions and colony-stimulating factors for prophylaxis and treatment of infectious complications in patients with hematologic malignant disorders

A. Busca, S. Cesaro, L. Teofili, M. Delia, C. Cattaneo, M. Criscuolo, F. Marchesi, N.S. Fracchiolla, C.G. Valentini, F. Farina, R. Di Blasi, L. Prezioso, A. Spolzino, A. Candoni, M.I. del Principe, L. Verga, A. Nosari, F. Aversa, L. Pagano

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)155-168
Number of pages14
JournalExpert Review of Hematology
Volume11
Issue number2
DOIs
Publication statusPublished - 2018

Keywords

  • biosimilar agent
  • colony stimulating factor
  • eltrombopag
  • erythropoietin
  • granulocyte colony stimulating factor
  • granulocyte macrophage colony stimulating factor, cancer patient
  • clinical evaluation
  • clinical practice
  • Cochrane Library
  • febrile neutropenia
  • granulocyte transfusion
  • hematologic malignancy
  • human
  • infection prevention
  • infectious complication
  • meta analysis (topic)
  • multicenter study (topic)
  • neutrophil
  • priority journal
  • randomized controlled trial (topic)
  • Review
  • systematic review

Cite this